FORA Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,615
Closed -$1.38M 483
2025
Q4
$1.38M Buy
13,615
+4,457
+49% +$358K 0.17% 158
2025
Q3
$501K Buy
+9,158
New +$458K 0.09% 281
2024
Q1
Sell
-6,708
Closed -$496K 454
2023
Q4
$496K Sell
6,708
-26,962
-80% -$1.77M 0.04% 332
2023
Q3
$2.3M Buy
33,670
+26,679
+382% +$2.26M 0.2% 144
2023
Q2
$656K Buy
+6,991
New +$545K 0.09% 206
2022
Q4
Sell
-8,465
Closed -$275K 528
2022
Q3
$275K Buy
+8,465
New +$349K 0.05% 342
2021
Q1
Sell
-499
Closed -$66K 872
2020
Q4
$66K Buy
+499
New +$60.3K 0.01% 737

Other funds holding EXAS

FORA Capital's EXAS Position: Q1 2026 in Review

FORA Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 13,615 shares — an estimated $1.38M sold.

FORA Capital first reported a position in EXAS in Q4 2020 and held it in 7 quarters. The position peaked at $2.3M in Q3 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • FORA Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 13,615 Exact Sciences shares in Q1 2026, an estimated $1.38M.
  • FORA Capital first reported a position in Exact Sciences in Q4 2020 and held it in 7 quarters.
  • FORA Capital's Exact Sciences position peaked at $2.3M in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.